Advertisement

Topics

Exalpha Biologicals, Inc Company Profile

13:54 EST 17th December 2018 | BioPortfolio

Nil

Location

5 Clock Tower Place, Suite 255
Maynard
Massachusetts
01754
United States of America

Contact

Phone: 800-395-1137 or 978-461-0435
Fax: 866-924-5100 or 978-461-0436
Email: info@exalpha.com


News Articles [49 Associated News Articles listed on BioPortfolio]

Health care in Iraq saves money by incorporating off-patent biologicals

Iraq is one of many countries determined to increase its budget savings by replacing appropriate originator biologicals with off-patent biologicals. This is due to the recognition of the proven impact...

FDA issues guidance for labelling biologicals and biosimilars

The US Food and Drug Administration (FDA) has issued two new guidance documents that provide recommendations to industry on labelling requirements for biologicals and biosimilars.

Precision BioLogic Acquires Affinity Biologicals

NewsPrecision BioLogic Inc. has completed the acquisition of Affinity Biologicals Inc., a manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics.

Positive results for Chinese rituximab and trastuzumab copy biologicals

Researchers from Shanghai Henlius Biotech have presented positive phase III study results for their rituximab [1] and trastuzumab [2] copy biologicals.

WuXi Biologics expands its biologicals manufacturing facilities

China-based WuXi Biologics, headquartered in Wuxi city of Jiangsu Province, is expanding its biologicals manufacturing capacity with new facilities planned in Ireland, China, Singapore and the US.

Originator biologicals and biosimilars under attack in UK and Japan

Originator biologicals makers and biosimilars makers are finding themselves facing litigation in both the UK and Japan.

Adalimumab copy biologicals accepted for review in China

China’s State Drug Administration (SDA) has accepted applications for approval of adalimumab copy biologicals from Hisun Pharma (Hisun) and Bio‑Thera Solutions (Bio‑Thera).

EMA studying pharmacovigilance for biologicals and biosimilars

New pharmacovigilance legislation was adopted by the European Parliament and European Council in December 2010. The European Medicines Agency (EMA) is responsible for implementing the legislation. As ...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 20%

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 25%

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...

PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

The analgesic potential of cytokine neutralization with biologicals.

Many acute and chronic inflammatory diseases, cancer and neuropathic disorders are accompanied by severe pain states reducing drastically the life quality of the patients. Biologicals which preferenti...

A large single hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents.

Large-scale studies of Drug Provocation Testing (DPT) or Rapid Drug Desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions OBJECTIVE...

Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

Biologicals targeting the interleukin (IL)-1β or IL-6 pathway are becoming prime choices for the treatment of children with systemic juvenile idiopathic arthritis (sJIA). Up to 1 in 3 sJIA children r...

Significant Drying Time Reduction using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.

Microwave-assisted freeze-drying is a rapid drying process well-known in food technology. However, little is known about its application to biologicals. In this study, we investigated the applicabilit...

History and perspectives on how to ensure antivenom accessibility in the most remote areas in Brazil.

A plan to achieve self-sufficiency in manufacturing biologicals for public health has been structured for the last 40 years in Brazil, in the context of a reform in the health system. Industrial plant...

Clinical Trials [273 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine co-administered with GSK Biologicals' 10-valent pneumococcal conjugate (GSK1024850A) vaccine ...

Companies [54 Associated Companies listed on BioPortfolio]

Exalpha Biologicals, Inc

Nil

Exalpha Biological Incorporated

Exalpha Corporation serves clinical researchers and scientists worldwide, offering the highest quality reagents for flow cytometry available anywhere. With guaranteed products ranging from the NuCycl ...

British Biologicals

British Biologicals is an Indian Nutraceutical company, founded in 1988 by Mr. V S Reddy. British Biologicals is headquartered at Bangalore and is popularly known as 'Th...

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

More Information about "Exalpha Biologicals, Inc" on BioPortfolio

We have published hundreds of Exalpha Biologicals, Inc news stories on BioPortfolio along with dozens of Exalpha Biologicals, Inc Clinical Trials and PubMed Articles about Exalpha Biologicals, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Exalpha Biologicals, Inc Companies in our database. You can also find out about relevant Exalpha Biologicals, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record